Rolan, Paul

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Agersø, H., Jensen, L. B., Elbrønd, B., Rolan, P., & Zdravkovic, M. (2002) · Diabetologia

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 510

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

Elbrønd, B., Jakobsen, G., Larsen, S., Agersø, H., Jensen, L. B., Rolan, P., Sturis, J., Hatorp, V., & Zdravkovic, M. (2002) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 279

Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial

Nenke, M. A., Haylock, C. L., Rankin, W., Inder, W. J., Gagliardi, L., Eldridge, C., Rolan, P., & Torpy, D. J. (2015) · Psychoneuroendocrinology

Adrenal Hormones and DisordersStress Responses and Cortisol

Cited by 32

The Relationship Between Androgens and Days per Month of Period Pain, Pelvic Pain, Headache, and TLR4 Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with Dysmenorrhoea

Evans, S. F., Kwok, Y., Solterbeck, A., Pyragius, C., Hull, M. L., Hutchinson, M. R., & Rolan, P. (2021) · Journal of Pain Research

Menstrual Health and DisordersEndometriosis Research and Treatment

Cited by 21

Androgens, Endometriosis and Pain

Evans, S. F., Hull, M. L., Hutchinson, M. R., & Rolan, P. E. (2021) · Frontiers in Reproductive Health

Endometriosis Research and TreatmentMenstrual Health and Disorders

Cited by 14

BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder

Papapetropoulos, S., Doolin, E., O’Connor, S., Paul, D., Odontiadis, M., Jaros, M., Rolan, P., & Stein, M. B. (2025) · NEJM Evidence

Posttraumatic Stress Disorder ResearchNicotinic Acetylcholine Receptors Study

Cited by 5

The Pathway to Proof-of-Concept for BNC210, a Negative Allosteric Modulator of the Alpha-7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease

Rolan, P., Doolin, E., Paul, D., Crossman, J., Odontiadis, M., Danjou, P., Smith, M., & Papapetropoulos, S. (2026) · Clinical Pharmacology in Drug Development

Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research

Cited by 3